Last reviewed · How we verify

NCT04877249

Gait Training in Post-Stroke Hemiparesis Hemiparesis

Completed NA Last updated 11 April 2025
What this trial tests

NA trial testing Split-belt treadmill training in Stroke in 69 participants. Completed in 28 March 2025.

Timeline
9 July 2021
Primary endpoint
5 June 2024
28 March 2025

Quick facts

Lead sponsorThe University of Texas Medical Branch, Galveston
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment69
Start date9 July 2021
Primary completion5 June 2024
Estimated completion28 March 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Medical Branch, Galveston

Who can join

20 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The focus of this study is to optimize the delivery of a combined strength and aerobic training regimen to individuals with post stroke hemiparesis and reduce overuse and inefficiencies associated with the nonparetic leg during walking. This study proposes to use 1) split-belt treadmill and 2) single belt treadmill walking using split belt simulation software for enhancing symmetrical walking patterns for people with stroke.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of backward-directed resistance on propulsive force generation during split-belt treadmill walking in non-impaired individuals.
    Moradian N, Ko M, Hurt CP, Brown DA. · · 2023 · cited 5× · PMID 38111676 · DOI 10.3389/fnhum.2023.1214967

Verify or expand the search:

Other trials of Split-belt treadmill training

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other The University of Texas Medical Branch, Galveston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04877249.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing